Carl L Gordon bought $2.0M of MBX
director, owner at MBX Biosciences, Inc.. 190,672 shares at an average of $10.60, traded Feb 14, 2025, filed Feb 19, 2025.
Score components
- +15RoleDirector
- +25Trade size$2.0M at market
- +3Relative to holdingsHoldings up 6%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000947871-25-000200, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 14, 2025 | POpen-market purchase Common Stockindirect: See footnotes | +17,962 | $9.90 | $178k | 3,176,390 | Feb 19, 2025 |
| Feb 14, 2025 | POpen-market purchase Common Stockindirect: See footnotes | +29,540 | $9.85 | $291k | 3,205,930 | Feb 19, 2025 |
| Feb 18, 2025 | POpen-market purchase Common Stockindirect: See footnotes | +49,070 | $10.84 | $532k | 3,255,000 | Feb 19, 2025 |
| Feb 18, 2025 | POpen-market purchase Common Stockindirect: See footnotes | +94,100 | $10.84 | $1.0M | 747,887 | Feb 19, 2025 |
Related signals
Other insiders at MBX Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 54Moderate | MBX Biosciences, Inc. | P. Kent Hawryluk President & CEO | $273k 20,000 shares | +4% | |
| 52Moderate | MBX Biosciences, Inc. | Steven L. Hoerter director | $265k 20,000 shares | - | |
| 51Moderate | MBXbuy MBX Biosciences, Inc. | Patrick J Heron director, owner | $12M 666,666 shares | +15% | |
| 45Moderate | MBXbuy MBX Biosciences, Inc. | Ora H. Pescovitz director | $45k 7,693 shares | +46% | |
| 54Moderate | MBX Biosciences, Inc. | P. Kent Hawryluk President & CEO | $535k 50,000 shares | +13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.